Healthcare
Colleen Cuffaro
Principal / East Coast
Since 2014
Colleen’s investment focus is early stage biopharmaceutical companies. Her interests lie in transformative medical technologies that deliver value to providers and patients alike. In her time at Canaan, Colleen helped launch the Canaan-Yale Fellowship program. Colleen previously worked as a chemist at Pharmaceutical Manufacturing and Research Services, Inc. She holds a Ph.D. in Cellular and Molecular Physiology from Yale University and a B.A. in Chemistry from the University of Pennsylvania.
Colleen in 5
Born and raised in Philadelphia
I love exploring new places, ideally by bicycle (Italy is #1 so far)
Irish, Scottish, and Italian descent
Swimming, biking, running, cooking, reading about cutting edge science
4X Ironman finisher
Investments
Current
Latest
Business Insider: Wende Hutton who’s worked in venture capital for 25 years shares her best career advice — and why it was worth being the first and only woman on her team when she started out
Endpoints News: The Endpoints 11: A group of disruptive upstarts on a do-or-die mission to launch new meds
Business Insider: Meet the 30 biotech leaders under 40 who are shaping the future of medicine
Fierce Biotech: Canaan unveils $800 million fund for fresh wave of biotech bets
Women of Venture in Healthcare: 30x return on investment . . . in each other
STAT: Biotech dreams of drugging the “undruggable”
GrowthCap: Top 40 Under 40 Growth Investors Of 2017
Genetic Engineering and Biotech News: Narrowing boardroom diversity divide
Body Politic Series: Women's access to healthcare
Colleen Cuffaro: Arrakis Therapeutics: Redefining the druggable target
Colleen in 5
Born and raised in Philadelphia
I love exploring new places, ideally by bicycle (Italy is #1 so far)
Irish, Scottish, and Italian descent
Swimming, biking, running, cooking, reading about cutting edge science
4X Ironman finisher